technology

Indra board keeps ceo escribano after failed em&e merger

Indra’s board met Wednesday and left the room with zero drama: Ángel Escribano stays chair, José Vicente De los Mozos keeps the CEO badge until June, and the Spanish defence-tech giant’s stock is still nursing a 4.2 % bruise from the government’s veto of its would-be marriage to Escribano Mechanical & Engineering.

The veto that never turned into a coup

SEPI, Madrid’s state-holding vehicle with 28 % of Indra’s capital, quietly torpedoed the tie-up last week. The plan was to weld Indra’s battlefield electronics empire to EM&E’s precision-machining know-how, forging what insiders called “Spain’s Rheinmetall”. Instead, the government signalled it wants Indra bigger, but not at the price of letting the founding Escribano clan tighten its grip. Tuesday’s 5 % share dip showed traders betting the chair would fall; Wednesday’s non-event proved them wrong.

Inside the Alcobendas headquarters the message was choreographed normalcy. Escribano showed up Tuesday to cosign a €700 m Hanwha deal that will birth a Spanish K9 howitzer plant—local steel, Korean design, European market. No mention of the board, no hint of surrender. Hours later he accepted the “IBEX-35 Executive of the Year” award from business daily Cinco Días, trophy in hand, smile locked.

June looms as the next battlefield

June looms as the next battlefield

De los Mozos’s mandate expires in three months. Renewal requires only a simple board majority, but politics is math plus noise. SEPI’s representatives can vote against, yet they would need allies; the free-float is 55 % and foreign funds have been buying the dip. Analysts at Renta 4 whisper that a second rejection of the EM&E merger could rekindle rebellion, especially if Madrid decides the “national champion” recipe needs a new chef.

Meanwhile the Hanwha contract books revenue through 2028 and gives Indra a domestic artillery beachhead—handy leverage when lobbying the same ministries that just blocked its M&A blueprint. The company’s next earnings call is pencilled for 28 February; expect pointed questions on whether organic growth can offset the forbidden inorganic shortcut.

Escribano survived today. The calendar, not the boardroom, will decide if he survives tomorrow.